Application of Risk Management Principles for Medical Devices

Risk Basics for Medical Devices

GCP & Pharmacovigilance Compliance Symposium | D3S03-1 - (BE): Clinical Study Conduct

Is My Product A Medical Device

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

Medical Device Quality Management System Regulation Design and Development

FDA Direct: Catching Up on Agency Reforms

FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S04 - (PV): International...

Medical Device Quality Management System Regulation Risk Management

Overview of the Quality System Regulation

FDA Expert Panel on Testosterone Replacement Therapy for Men

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S07 – Q&A Discussion Panel

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S03-2 – Q&A Discussion Panel

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

Public Meeting: Reauthorization of the Biosimilar User Fee Act

2025 FDA Achievements

November 13, 2025: Pediatric Advisory Committee Meeting (PAC)

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S06 - (PV): Regulatory Updates

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

FDA Direct: FDA Awards Six National Priority Vouchers